Recent News

• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - Cantor Global Healthcare Conference 2025
• 09.03.2025 - 2025 Wells Fargo Healthcare Conference
• 09.02.2025 - Citi's 2025 Biopharma Back to School Conference
• 08.26.2025 - Innoviva to Participate in Upcoming Investor Conferences
• 08.13.2025 - Innoviva Specialty Therapeutics’ Antimicrobial Therapies ZEVTERA® and XACDURO® Nominated for the 2025 Prix Galien USA Best Pharmaceutical Product Award
• 08.11.2025 - Trevor Allred
• 08.06.2025 - Innoviva Reports Second Quarter 2025 Financial Results; Highlights Recent Company Progress
• 07.14.2025 - Raghuram Selvaraju
• 07.14.2025 - Steve Seedhouse

Recent Filings

• 08.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.06.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.06.2025 - 8-K Current report
• 08.06.2025 - EX-99.1 EX-99.1
• 08.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors